Recombinant Xenopus laevis Monoacylglycerol lipase abhd6-B (abhd6-b), partial

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your preferred format in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, provided as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing.
The specific tag type is determined during production. If you require a specific tag, please inform us for preferential development.
Synonyms
abhd6-bMonoacylglycerol lipase abhd6-B; EC 3.1.1.23; Abhydrolase domain-containing protein 6-B
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Xenopus laevis (African clawed frog)
Target Names
abhd6-b
Uniprot No.

Target Background

Function
Monoacylglycerol lipase with a preference for hydrolyzing medium-chain saturated monoacylglycerols, including 2-arachidonoylglycerol. Its 2-arachidonoylglycerol degradation activity may modulate endocannabinoid signaling. It also exhibits lysophosphatidyl lipase activity, favoring lysophosphatidylglycerol among other lysophospholipids. Furthermore, it degrades bis(monoacylglycero)phosphate (BMP), representing the primary enzyme for BMP catabolism. BMP, also known as lysobisphosphatidic acid, is enriched in late endosomes and lysosomes and plays a crucial role in intraluminal vesicle formation and lipid sorting.
Database Links

KEGG: xla:380544

UniGene: Xl.29371

Protein Families
AB hydrolase superfamily
Subcellular Location
Late endosome membrane; Single-pass type II membrane protein. Lysosome membrane; Single-pass type II membrane protein. Mitochondrion membrane; Single-pass type II membrane protein.

Q&A

What is the functional role of ABHD6-B in Xenopus laevis?

ABHD6-B in Xenopus laevis functions primarily as a lipase that hydrolyzes monoacylglycerols (MAGs), particularly 2-arachidonoylglycerol (2-AG), an important endocannabinoid. ABHD6 is part of the α/β hydrolase domain-containing family and plays key roles in lipid metabolism. In Xenopus, ABHD6 serves multiple functions:

  • Degradation of bis(monoacylglycero)phosphate (BMP), which is enriched in late endosomes/lysosomes

  • Regulation of endocannabinoid signaling through 2-AG hydrolysis

  • Participation in late endosomal/lysosomal lipid-sorting machinery

  • Modulation of energy metabolism and lipid homeostasis

Unlike mammals which express a single ABHD6 gene, Xenopus laevis expresses two homeologs (abhd6-a and abhd6-b) due to its pseudotetraploid genome resulting from genome duplication approximately 30 million years ago .

How does Xenopus laevis ABHD6-B compare structurally to mammalian ABHD6?

Xenopus laevis ABHD6-B shares significant structural homology with mammalian ABHD6, though with some key differences:

  • Both contain a characteristic α/β hydrolase fold with a catalytic triad (Ser, Asp, His) in the active site

  • The protein contains eight central β-sheets that form a partial β-barrel surrounded by eight α-helices

  • A lid-domain composed of residues 151-225 fashioned by helices α4-α6 covers the β-sheets and active site

  • The Xenopus enzyme maintains the conserved transmembrane domain that anchors the protein to membranes

  • Sequence analysis shows preservation of key functional domains while maintaining species-specific variations

Structural conservation between Xenopus and mammalian ABHD6 suggests evolutionary importance of this enzyme, similar to how other proteins like the LDL receptor maintained structural conservation between species .

What expression systems are recommended for producing recombinant Xenopus laevis ABHD6-B?

Several expression systems have proven effective for producing recombinant Xenopus proteins including ABHD6-B:

E. coli-based expression:

  • Prokaryotic expression using pET or pGEX vectors with BL21(DE3) cells

  • Often requires optimization of codons for bacterial expression

  • Typically produces inclusion bodies requiring refolding protocols

  • Better suited for partial protein domains than full-length ABHD6-B

Xenopus oocyte/embryo expression:

  • Direct mRNA injection into Xenopus oocytes or early embryos

  • Allows post-translational modifications similar to native protein

  • Embryos show high protein production capacity with low background

  • Can be used with genetic code expansion technologies for specialized studies

Mammalian cell expression:

  • HEK293T or COS-7 cells using pcDNA3.1 or similar vectors

  • Provides proper folding and post-translational modifications

  • Allows study of membrane integration and trafficking

  • Recommended for full-length ABHD6-B with transmembrane domains

Each system offers distinct advantages depending on downstream applications and desired protein characteristics.

What approaches can be used to study the membrane association and subcellular localization of Xenopus ABHD6-B?

Understanding the membrane association and subcellular localization of Xenopus ABHD6-B requires multiple complementary techniques:

Subcellular fractionation:

  • Differential centrifugation of Xenopus tissue homogenates or cells expressing recombinant ABHD6-B

  • Sucrose density-gradient centrifugation to separate organelles

  • Western blot analysis of fractions using anti-ABHD6 antibodies and organelle markers

  • Activity assays in isolated membrane fractions

Confocal microscopy and live cell imaging:

  • Fluorescent protein fusions (GFP-ABHD6-B) for live cell tracking

  • Immunofluorescence with anti-ABHD6 antibodies in fixed cells/tissues

  • Co-localization studies with markers for late endosomes/lysosomes

  • Super-resolution microscopy for detailed membrane topology

Membrane integration analysis:

  • Alkaline carbonate extraction to distinguish peripheral vs. integral membrane proteins

  • Protease protection assays to determine topology

  • Hydrogen exchange mass spectrometry (HX-MS) using nanodisc technology to identify membrane-interacting domains

ABHD6 co-localizes with late endosomes/lysosomes in mammalian cells and exhibits activity at cytosolic pH rather than acidic lysosomal pH, suggesting it degrades BMP exported from acidic organelles or de novo-formed BMP . Similar approaches would be valuable for characterizing Xenopus ABHD6-B localization.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.